Categories
Cancer Clinical trials Medicine

No, the New York Times did not “kill your patient.”

One of the more depressing things about getting much more interested in the debate over how we should screen for common cancers, particularly breast and prostate cancer, is my increasing realization of just how little physicians themselves understand about the complexities involved in weighing the value of such tests. It’s become increasingly apparent to me […]

Categories
Cancer Complementary and alternative medicine Medicine Quackery

One more example of the price of refusing science-based cancer therapy

Another year, another Breast Cancer Awareness Month. While most people who have either been touched by breast cancer or who have a professional interest in it, the significance of Breast Cancer Awareness Month is that it is a time, well, to increase awareness and to promote breast cancer research. There is another side to Breast […]

Categories
Cancer Complementary and alternative medicine Quackery

A different kind of breast cancer testimonial

For my international readers, it’s a holiday here in the U.S. That means I plan on taking it easy, which means I’ve decided on doing, in essence, a “rerun.” I chose this particular rerun based on my post from last Thursday. I thought that rerunning this particular post is a good reminder of what the […]

Categories
Cancer Complementary and alternative medicine Homeopathy Medicine Quackery

Yet another dubious breast cancer cure testimonial

[NOTE: Please be sure to read the addendum!] I hate cancer quackery. I know, I know, regular readers probably figured that out by now, and even new readers rarely take more than a couple of weeks to figure it out. That’s because cancer quackery is a frequent topic on this blog. One of the most […]

Categories
Cancer Politics

"Overselling" mammography?

One issue that keeps coming up time and time again for me is the issue of screening for cancer. Because I’m primarily a breast cancer surgeon in my clinical life, that means mammography, although many of the same issues come up time and time again in discussions of using prostate-specific antigen (PSA) screening for prostate […]